NanoRepro AG (ETR: NN6)
Germany
· Delayed Price · Currency is EUR 1.470
+0.085 (6.14%)
Jan 13, 2025, 5:36 PM CET
NanoRepro AG Revenue
NanoRepro AG had revenue of 1.77M EUR in the half year ending June 30, 2024, a decrease of -93.17%. This brings the company's revenue in the last twelve months to 3.56M, down -74.98% year-over-year. In the year 2023, NanoRepro AG had annual revenue of 3.18M, down -91.79%.
Revenue (ttm)
3.56M
Revenue Growth
-74.98%
P/S Ratio
5.12
Revenue / Employee
161.93K
Employees
18
Market Cap
18.23M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 3.18M | -35.61M | -91.79% |
| Dec 31, 2022 | 38.79M | -124.00M | -76.17% |
| Dec 31, 2021 | 162.79M | 145.86M | 861.58% |
| Dec 31, 2020 | 16.93M | 15.12M | 837.58% |
| Dec 31, 2019 | 1.81M | -942.90K | -34.31% |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
| Dec 31, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Merck KGaA | 20.96B |
| Siemens Healthineers AG | 22.36B |
| Fresenius SE & Co. KGaA | 22.81B |
| Bayer Aktiengesellschaft | 46.74B |
| Sartorius Aktiengesellschaft | 3.32B |
| Fresenius Medical Care AG | 19.24B |
| Carl Zeiss Meditec AG | 2.07B |
| SCHOTT Pharma AG & Co. KGaA | 957.09M |